April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
The Intracameral Injection of Antigen Amplifies Splenic CD8+ regulatory T cells Induced by Immunization
Author Affiliations & Notes
  • Yen Lemire
    Immunology, University of Connecticut Health Center, Farmington, Connecticut
  • Roshanak Sharafieh
    Immunology, University of Connecticut Health Center, Farmington, Connecticut
  • Sabrina Powell
    Immunology, University of Connecticut Health Center, Farmington, Connecticut
  • James O'Rourke
    Immunology, University of Connecticut Health Center, Farmington, Connecticut
  • Robert E. Cone
    Immunology, University of Connecticut Health Center, Farmington, Connecticut
  • Footnotes
    Commercial Relationships  Yen Lemire, None; Roshanak Sharafieh, None; Sabrina Powell, None; James O'Rourke, None; Robert E. Cone, None
  • Footnotes
    Support  NIH Grant EY017289 , 017537and the Connecticut Lions Eye Research Foundation
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2265. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yen Lemire, Roshanak Sharafieh, Sabrina Powell, James O'Rourke, Robert E. Cone; The Intracameral Injection of Antigen Amplifies Splenic CD8+ regulatory T cells Induced by Immunization. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2265.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The intracameral injection of antigen recruits circulating F4/80+ cells to the anterior chamber that recirculate through the anterior chamber (AC) to the thymus and to the spleen where CD8+ regulatory T cells are induced. Because these regulatory T cells specifically suppress active cell-mediated immunity, it is likely that there is a quantifiable increase in the number of these regulatory T cells during immunization. To test this hypothesis, we quantified the number of splenic, antigen-specific CD8+ regulatory T cells induced by the injection of antigen into the AC of naïve and immunized mice.

Methods: : Mice were immunized one week after receiving an intracameral injection of TNP-BSA or ovalbumin (OVA) or were not immunized. The suppression of the expression of contact sensitivity to the immunizing antigen in immunized mice by splenic regulatory T cells was quantified by the injection of graded numbers of AC-induced total splenic or CD8+ T cells concurrent with the challenge antigen into the footpads of immunized mice. The number of splenic regulatory cells required to effect a 50% reduction in the swelling of the challenge site was taken as a metric to quantify the regulatory T cells.

Results: : The antigen-specific suppression of the expression of contact sensitivity by AC-induced regulatory spleen cells was proportional to the number of cells injected into a footpad challenged by antigen. The intracameral injection of antigen induces only antigen-specific CD8+ regulatory T cells that are specifically increased at least 3-4 fold when the mice are immunized. Splenic CD8+ regulatory spleen cells induced by the intracameral injection of antigen are stable at the challenge site no more than 3 days after injection.

Conclusions: : The intracameral injection of antigen quantitatively expands splenic CD8+ regulatory T cells induced by immunization. Quantifying these regulatory T cells provides an improved basis for quantifying anterior chamber-associated immune deviation (ACAID).

Keywords: ACAID • immunomodulation/immunoregulation • immune tolerance/privilege 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×